|
The University of Ottawa’s Heart Institute is getting over $1 million to find ways to improve the outcomes for people with COVID-19 by using common heart health medications. According to an upcoming study out of the institute, cardiovascular disease is a leading killer in COVID-19 patients. Elderly patients who had had heart attacks, strokes, hypertension or diabetes, have a higher risk of infection from the virus.
|